[1] PubMed ID: | 35149838 |
Disease Name: | Colorectal Neoplasms |
Sample: | CRLM tissues and cells |
Dysfunction Pattern: | Interaction(GLUT1) |
Validated Method: | qRT-PCR//RNA Pull-Down//Western Blot |
Description: | Here, we report an lncRNA, GAL (glucose transporter 1 (GLUT1) associated lncRNA), that was upregulated in CRLM tissues compared with primary colorectal cancer (CRC) tissues or matched normal tissues and was associated with the overall survival rates of CRLM patients. Mechanistically, GAL interacted with the GLUT1 protein to increase GLUT1 SUMOylation, inhibiting the effect of the ubiquitin-proteasome system on the GLUT1 protein. |
Causality: | Yes |
Causal Description: | Functionally, GAL served as an oncogene because it promoted CRC cell migration and invasion in vitro and enhanced the ability of CRC cells to metastasize from the intestine to the liver in vivo. |
Clinical-realted Application: | Here, we report an lncRNA, GAL (glucose transporter 1 (GLUT1) associated lncRNA), that was upregulated in CRLM tissues compared with primary colorectal cancer (CRC) tissues or matched normal tissues and was associated with the overall survival rates of CRLM patients. F |
|